Bandingkan Harga & Kinerja Inti Agri Resources Tbk (IIKP) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Inti Agri Resources Tbk dan Organon Pharma Indonesia Tbk.: Inti Agri Resources Tbk diperdagangkan di Rp50 (kapitalisasi pasar 1,68 T), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Inti Agri Resources Tbk jauh lebih besar — sekitar 16,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IIKP | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,68 T | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Inti Agri Resources Tbk
Established on March 16th 1999 in Surakarta, PT. Inti Indah Karya Plasindo conduct in HD`s type Plastick Packaging Industri. On April 1 th 2005 the Company's name has been changed to PT Inti Kapuas Arowana Tbk. Responding to growing opportunities and potentials in Arowana Fish market, PT Inti Kapuas Arowana (IIKP) repositioned its business by focusing on selling and farming of Arowana Fish. Through the company’s subsidiary, PT. Istana Bahari, IIKP entered into a partnership with traditional arowana farm in Pontianak, West Kalimantan. In parallel, the company also purchased 24 hectares (62 acres) land. They are both to be developed into a modern fish farming facility.In marketing Super Red Arowana, IIKP develops a brand name “Shelook RED” to represent the high quality standard assurance that IIKP applies in the breeding, selection, and care of its Arowana Fish.
Selengkapnya di halaman IIKP →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
